Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sean T. Massa is active.

Publication


Featured researches published by Sean T. Massa.


Oral Oncology | 2017

Competing causes of death in the head and neck cancer population.

Sean T. Massa; Nosayaba Osazuwa-Peters; Kara M. Christopher; Lauren D. Arnold; Mario Schootman; Ronald J. Walker; Mark A. Varvares

PURPOSE/OBJECTIVES The increasing survivorship of head and neck squamous cell carcinoma (HNSCC) comes with a risk of death from other causes, known as competing causes. The demographics of HNSCC are also evolving with increasing incidence of Human Papillomavirus (HPV) associated tumors. This study describes competing causes of death for the HNSCC population compared to the general population and identifies associated risk factors. METHODS Adult patients with first mucosal HNSCC (2004-2011) were identified from the Surveillance, Epidemiology and End Result database. Competing causes of death were compared to reference populations using proportion of deaths and Standardized Mortality Ratios (SMR). A multivariable competing risk survival analysis yielded subdistribution hazard ratios (HR) for competing mortality. RESULTS Of 64,598 HNSCC patients, 24,602 (38.1%) were deceased including 7142 deaths (29.0%) from competing causes. The most common were cardiovascular disease, lung cancer, and other cancers. All relative mortality rates were elevated, especially liver disease (SMR 38.7; 95% CI: 29.4-49.3), suicide (SMR 37.1; 95% CI: 26.1-48.6), and subsequent primary cancers (SMR 7.5; 95% CI: 6.78-8.32). Demographic and tumor factors independently increased risk of competing mortality, including age (HR per 5years 1.24; 95% CI: 1.22-1.25), sex (male HR 1.23; 95% CI: 1.16-1.32), race (Black HR 1.17; 95% CI: 1.09-1.26), insurance (uninsured HR 1.28; 95% CI: 1.09-1.50), and marital status (single HR 1.29; 95% CI: 1.21-1.37). CONCLUSION Nearly one in three HNSCC patients died from competing causes. When developing long term survivorship regimens for HNSCC patients, clinicians should be familiar with this populations specific risks.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2016

Improved overall survival and mortality in head and neck cancer with adjuvant concurrent chemoradiotherapy in national databases.

Sonia S. Lin; Sean T. Massa; Mark A. Varvares

Many studies have demonstrated the advantage of postoperative concurrent chemoradiotherapy (CRT) over radiotherapy (RT) alone in locoregional control, but few have examined overall survival with respect to national databases.


Oral Oncology | 2017

40-year incidence trends for oropharyngeal squamous cell carcinoma in the United States

Nosayaba Osazuwa-Peters; Matthew C. Simpson; Sean T. Massa; Eric Adjei Boakye; Jastin L. Antisdel; Mark A. Varvares

OBJECTIVES To determine differences in oropharyngeal squamous cell carcinoma (OPSCC) incidence between 1975 and 2014 stratified by race, sex, and age. MATERIALS AND METHODS We obtained age-adjusted OPSCC incidence rates for race and sex groups from 1975 to 2014 using the Surveillance, Epidemiology, and End Results 9 database. We defined OPSCC as cancers of the base of tongue, lingual/palatine tonsil, oropharynx, soft palate, uvula, and Waldeyers ring. We used Joinpoint analyses to determine incidence trends for race/sex/age groupings. RESULTS There were 38,624 oropharyngeal primary tumors in the analyses. Males accounted for 74% of sample population, and whites accounted for 84% of tumors. Overall, there was a 57.3% increase in incidence of oropharyngeal between 1975 and 2014. For blacks and whites, average incidence was lower for females than males. Rates for black males aged ≥50years was highest for most of the follow-up time but decreased sharply around 1988 and were surpassed by the significant increase in incidence in white males aged 50-59 (1995-2014 APC=4.07, p<0.001) and ≥60years (2002-2014 APC=4.25, p<0.001). For males aged ≥60, whites had higher rates than blacks starting in 2010. OPSCC incidence in White males (10.99 per 100,000 person-years) surpassed rates in Blacks (10.14 per 100,000 person-years) beginning in 2008. CONCLUSION OPSCC has significantly increased in the United States in the last 40 years. This overall increase in OPSCC can primarily be attributed to white males. OPSCC prevention and early detection efforts could target these demographic factors to decrease rising OPSCC incidence.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2017

Decreased cancer‐independent life expectancy in the head and neck cancer population

Sean T. Massa; Lauren M. Cass; Nosayaba Osazuwa-Peters; Kara M. Christopher; Ronald J. Walker; Mark A. Varvares

Aside from cancer mortality, patients with head and neck cancer have increased mortality risk. Identifying patients with the greatest loss of cancer‐independent life expectancy can guide comprehensive survivorship programs.


JAMA Oncology | 2017

Primary Cancer vs Competing Causes of Death in Survivors of Head and Neck Cancer

Matthew C. Simpson; Sean T. Massa; Eric Adjei Boakye; Jastin L. Antisdel; Katherine A. Stamatakis; Mark A. Varvares; Nosayaba Osazuwa-Peters

that by releasing panelists’ names they would be subject to lobbying by numerous entities. This proposed legislation and the California Association of Health Plans’ response highlight the concern and complexity around OCP transparency. Collaboration with industry is key to innovation; however, to ensure patient and clinician trust and maintain their momentum in the value space, pathway developers will need to be transparent about FCOI and how those interests are managed. Many vendors have begun this process, and 1 suggestion would be to take guidance from the Institute of Medicine’s recommendations for groups charged with clinical practice guideline development.6


Archive | 2018

Evidence-Based Practice: Functional Rhinoplasty

Sean T. Massa; Zachary Farhood; Scott Walen

Chronic nasal obstruction is common and is often attributable to nasal valve obstruction. Functional rhinoplasty consists of a group of techniques aimed to relieve nasal valve obstruction. Symptom improvement can be reliably achieved using traditional grafting techniques; however, symptoms persist in a subset of patients. Novel evaluation tools strive to improve patient selection for specific treatments. Concurrently, emerging techniques have built on the success of traditional functional rhinoplasty. The overlap between functional and aesthetic rhinoplasty continues to blur. With functional implications of aesthetic surgery now well established, the cosmetic impact of functionally oriented surgery is increasingly recognized.


Laryngoscope | 2018

Demographic predictors of head and neck cancer survival differ in the elderly: HNSCC Survival Predictors in the Elderly

Sean T. Massa; Lauren M. Cass; Sai Deepika Challapalli; Zisansha Zahirsha; Matt Simpson; Gregory Ward; Nosayaba Osazuwa-Peters

Head and neck squamous cell carcinoma (HNSCC) prognosis strongly correlates with demographic factors. This study aimed to determine whether demographic predictors of HNSCC survival differ between age cohorts, with an emphasis on the growing elderly demographic.


Cancer Epidemiology, Biomarkers & Prevention | 2018

Abstract A87: Which head and neck cancer patient benefits from being married: The man or the woman?

Nosayaba Osazuwa-Peters; Matthew C. Simpson; Lauren M. Cass; Sai Deepika Challapalli; Zisansha Zahirsha; Eric Adjei Boakye; Sean T. Massa

Introduction: Among the known nonclinical prognostic factors for head and neck squamous cell carcinoma (HNSCC) survivorship, there has been recent focus on the potential benefits of being married. Several studies have shown that marriage confers a survival advantage for HNSCC patients. However, anecdotal evidence suggests that there may be marked differences in this survival benefit based on the sex of the patient. To date, no study has described how sex differences influence head and neck cancer survivorship based on marital status. Our study aimed to determine whether marital status at diagnosis impacts survivorship of HNSCC differently based on sex. Methods: In this retrospective study, we utilized a patient cohort of 27,208 confirmed HNSCC cases from the Surveillance, Epidemiology, and End Results (SEER) 18 database (2004–2014) who received chemotherapy and radiotherapy. Actuarial survival curves stratified by marital status at diagnosis (married/partnered, never married, divorced/separated, widowed) indicated cancer-specific survival from HNSCC. Survival differences between marital status groups were first assessed by log-rank tests with Bonferroni adjustments. Second, patients9 demographic and clinical characteristics including sex, marital status, race/ethnicity, insurance status, HNSCC site, stage, age at diagnosis, year of diagnosis, and county-level poverty were utilized in Fine and Gray competing risk proportional hazard models to examine the potential interaction between sex and marital status and estimate adjusted hazard ratios (aHR) for death from HNSCC. Results: The cohort was mostly men (80.8%) and married/partnered (56.5%). Married/partnered patients had the best survival of any marital status group (log-rank and Bonferroni p Conclusions: Our study has shown for the first time in the head and neck cancer literature that while being married confers survival benefits in general, married men with HNSCC may benefit more than women. Unmarried men seemed to fare the worst compared with every marital status for both men and women. More research is needed to understand this differential marital status benefit based on sex. Additionally, efforts should focus on developing analogous support systems for men and women who are head and neck cancer patients that could improve their survival, especially unmarried men and widowed men and women. Citation Format: Nosayaba Osazuwa-Peters, Matthew C. Simpson, Lauren M. Cass, Sai Deepika Challapalli, Zisansha S. Zahirsha, Eric Adjei Boakye, Sean T. Massa. Which head and neck cancer patient benefits from being married: The man or the woman? [abstract]. In: Proceedings of the Tenth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2017 Sep 25-28; Atlanta, GA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2018;27(7 Suppl):Abstract nr A87.


Cancer Epidemiology, Biomarkers & Prevention | 2018

Abstract C54: Survival outcomes for head and neck patients with Medicaid: A health insurance paradox

Nosayaba Osazuwa-Peters; Matthew C. Simpson; Sean T. Massa; Eric Adjei Boakye; Lauren M. Cass; Sai Deepika Challapalli; Rebecca L. Rohde; Mark A. Varvares

Introduction: Although there are currently more than 430,000 head and neck cancer (HNC) survivors in the United States, it is accepted that many more patients would have survived longer if they presented at an earlier stage. Less than half of all head and neck cancer patients present with early-stage disease. One of the factors implicated in late stage of presentation for head and neck cancer patients is access to care, driven by health insurance status. While individuals with health insurance are known to present earlier, less is known about outcome differences for patients who are uninsured or who have Medicaid insurance. We have observed many head and neck cancer patients initially present without insurance despite qualifying for Medicaid, and so are assisted with obtaining insurance before discharge. This process blurs the line between uninsured and Medicaid patients. The aim of this study was to determine whether there are disparities in survival outcomes for HNC patients based on whether they are insured, uninsured, or have Medicaid insurance. Methods: A cohort of 49,524 patients aged 18-64 years with first primary HNC from the Surveillance, Epidemiology, and End Results (SEER) 18 database diagnosed from 2007-2014 was included. Actuarial survival curves stratified by insurance status (insured, Medicaid, and uninsured) were created to determine HNC-specific survival differences between the groups with a log-rank test. Patient characteristics including insurance, race/ethnicity, sex, county-level poverty, surgery, marital status, tumor site, stage, year of diagnosis, and age at diagnosis were utilized in a Fine and Gray competing risk proportional hazard model to compute adjusted hazard ratios (aHR) for cause-specific death from HNC. Multinomial logistic regression was also performed to determine characteristics of patients with each type of insurance by adjusted odds ratios (aOR). Results: The cohort was mostly male (75.6%) and insured (73.6%), with 18.6% on Medicaid and 7.8% uninsured. At the end of the 7-year follow-up period, HNC-specific survival rate was significantly lower for patients on Medicaid (49.5%) than uninsured (54.8%) and insured patients (74.2%) (log-rank p Conclusion: While patients with health insurance had better survival outcome in general, our study showed that patients with Medicaid did not have a better survival outcome than those without any insurance after adjusting for all other prognostic factors, including stage of presentation and treatment modality. Medicaid patients, in fact, had worse outcome than uninsured HNC patients. It could be that despite having insurance, Medicaid patients did not have adequate access to care and thus had delayed presentations. Our findings highlight the need to bridge the health insurance gap for HNC patients to increase survivorship. Citation Format: Nosayaba Osazuwa-Peters, Matthew C. Simpson, Sean T. Massa, Eric Adjei Boakye, Lauren M. Cass, Sai Deepika Challapalli, Rebecca L. Rohde, Mark A. Varvares. Survival outcomes for head and neck patients with Medicaid: A health insurance paradox [abstract]. In: Proceedings of the Tenth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2017 Sep 25-28; Atlanta, GA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2018;27(7 Suppl):Abstract nr C54.


Cancer | 2018

Survival of human papillomavirus-associated cancers: Filling in the gaps: HPV-Associated Cancer Survival

Nosayaba Osazuwa-Peters; Sean T. Massa; Matthew C. Simpson; Eric Adjei Boakye; Mark A. Varvares

Nearly 80 million individuals are currently infected with human papillomavirus (HPV) in the United States, making it the most common sexually transmitted infection. The oncogenic strains of HPV are associated with virtually all cases of cervical cancer (including cancer in situ), 91% of anal cancer, 75% of vaginal cancer, 70% of oropharyngeal cancer, 69% of vulvar cancer, and 63% of penile cancer. In the last decade, it has been demonstrated that several rectal cancers could be associated with HPV because of the proximity of the anus and the rectum. Together, these HPV-associated cancers cost 7.5 million years of potential life lost and

Collaboration


Dive into the Sean T. Massa's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mark A. Varvares

Massachusetts Eye and Ear Infirmary

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge